For more information about our phases, hover with your mouse over the individual phases
Phase 1
Scientific pre-testsPhase 2
Consultation of authorities and official field testsPhase 3
Dossier preparation and submissionPhase 4
Regulatory review of the dossierPhase 5
Approval and market launchPhase 1: Scientific pre-tests
Phase 2: Regulatory dialogue and official field trials
Phase 3: Dossier preparation and submission
Phase 4: Regulatory review of the dossier
Phase 5: Approval and market launch
Status: Phase 2
legal registration
40%
Our initial product ESCApe against the grapevine disease ESCA is currently in phase 2, in which discussions with the authorities and field trials required for approval are being conducted.
Status: Phase 1
legal registration
11%
To also bring a biological variant of ESCApe to market in the medium term, we are currently conducting preliminary scientific trials.